Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostatic Neoplasms, Prostatectomy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT02173522
What this trial is testing

Phase II Investigation of Prostate Artery Embolization (PAE) Before Radical Prostatectomy in Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Shivank Bhatia 4
Not applicableUnknownNCT06677775
What this trial is testing

Pathological Positivity Rate in Prostate Cancer Patients with PI-RADS 4 and First Negative Biopsy

Who this might be right for
Prostate Cancer
Anhui Provincial Hospital 30
Not applicableActive Not RecruitingNCT04269512
What this trial is testing

Role of Lymphnode Dissection in Men With Prostate Cancer Treated With Radical Prostatectomy

Who this might be right for
Prostate Cancer
Martini-Klinik am UKE GmbH 3,650
Testing effectiveness (Phase 2)WithdrawnNCT03035357
What this trial is testing

Neoadjuvant Listeria or Daratumumab in Prostate Cancer

Who this might be right for
Malignant Neoplasms of Male Genital OrgansProstate Cancer
M.D. Anderson Cancer Center
Not applicableLooking for participantsNCT06776172
What this trial is testing

Extended vs. No Pelvic Lymph Node Dissection During Radical Prostatectomy. DISSECTION 2.0.

Who this might be right for
Prostate Cancer SurgeryProstate Cancers
University Hospital, Basel, Switzerland 400
Not applicableLooking for participantsNCT07077239
What this trial is testing

Prostate Cancer Postoperative Stereotactic Body Radiotherapy With Adaptive Technology for Minimizing Toxicity

Who this might be right for
Prostate Cancer (CRPC)
Jonsson Comprehensive Cancer Center 200
Testing effectiveness (Phase 2)Ended earlyNCT01650285
What this trial is testing

Cabazitaxel and Radiation For Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Brown University 5
Not applicableStudy completedNCT01347476
What this trial is testing

Aggressive Prostate Cancers in Elderly Patients

Who this might be right for
Prostatic Neoplasms
Seoul National University Hospital 1,333
Testing effectiveness (Phase 2)Study completedNCT00844792
What this trial is testing

Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer

Who this might be right for
Cancer of the ProstateProstate CancerProstatic Neoplasms
University Health Network, Toronto 48
Large-scale testing (Phase 3)WithdrawnNCT05363644
What this trial is testing

BioDFence® G3 For Full Nerve-Sparing Robotic-Assisted Radical Prostatectomy

Who this might be right for
Prostate CancerProstatectomyErectile Dysfunction Following Radical Prostatectomy+1 more
AdventHealth
Not applicableStudy completedNCT03668652
What this trial is testing

Focal Prostate Ablation Versus Radical Prostatectomy

Who this might be right for
Prostate Cancer
Oslo University Hospital 213
Not applicableStudy completedNCT03241758
What this trial is testing

Vascular Changes Of Patients Undergoing Laparoscopic Radical Prostatectomy

Who this might be right for
Prostatic NeoplasmsErectile Dysfunction Following Radical Prostatectomy
Corporacion Parc Tauli 110
Large-scale testing (Phase 3)Not Yet RecruitingNCT07830511
What this trial is testing

RIsk aDapted Stereotactic Radiotherapy vs. standarD of Care Radiotherapy in Patients With Prostate Cancer in the Adjuvant or saLvage sEtting With or Without Lymph Node Irradiation (RIDDLELN) - A Phase III Trial

Who this might be right for
Prostate Cancer (Post Prostatectomy)Prostate CancerSBRT
Robert Förster 206
Not applicableEnded earlyNCT01007214
What this trial is testing

Guided Biopsy for Mapping Prostate Cancer

Who this might be right for
Prostate Cancer
Roswell Park Cancer Institute 7
Testing effectiveness (Phase 2)Looking for participantsNCT07450599
What this trial is testing

Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Before Surgery for Men Who Have High-risk Localized Prostate Cancer.

Who this might be right for
High-risk Localized Prostate Cancer
Bayer 250
Not applicableStudy completedNCT02131649
What this trial is testing

PET/MRI for Men Being Considered for Radiotherapy for Suspected Prostate Cancer Recurrence Post-Prostatectomy

Who this might be right for
Prostate Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 99
Large-scale testing (Phase 3)Active Not RecruitingNCT01407263
What this trial is testing

Trial of Modifications to Radical Prostatectomy

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 3,204
Not applicableWithdrawnNCT01718704
What this trial is testing

Viberect Penile Vibratory Stimulation to Enhance Recovery of Erectile Function and Urinary Continence Post-Prostatectomy

Who this might be right for
Erectile Dysfunction Following Radical ProstatectomyUrinary Incontinence of Non-organic Origin
Johns Hopkins University
Not applicableActive Not RecruitingNCT05746806
What this trial is testing

Trial of Ultrahypofractionated Focal Salvage Radiotherapy for Isolated Prostate Bed Recurrence After Radical Prostatectomy

Who this might be right for
Recurrent Prostate Cancer
Insel Gruppe AG, University Hospital Bern 36
Early research (Phase 1)Study completedNCT05617885
What this trial is testing

Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer

Who this might be right for
Metastatic Prostate CancerNon-metastatic Prostate CancerProstate Cancer
Praful Ravi, MB BCHir, MRCP 9
Next Page